Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.36 -0.11 (-1.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Acquisitions (2023)

Updated

Zevra Therapeutics' Acquisitions came in at $30.4 million for Q4 2023.

Analysis

Zevra Therapeutics (ZVRA) Acquisitions (2023) Analysis & Trends

  • Going back by year, Acquisitions was $14.09 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Zevra Therapeutics 612.56 Mn -200.15 Mn 38.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 30.40 Mn
API Access

Zevra Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ZVRA&period=max&api_key=YOUR_API_KEY